|
1）Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244: 359-62
|
|
|
|
2）Kapoor A, Simmonds P, Gerold G, et al. Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A. 2011; 108(28): 11608-13
|
|
|
|
|
3）Burbelo PD, Dubovi EJ, Simmonds P, et al. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol. 2012; 86(11): 6171-8
|
|
|
|
|
|
4）Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76
|
|
|
|
|
|
5）Takayama K, Inamura M, Kawabata K, et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4a transduction, Mol Ther. 2012; 20(1): 127-37
|
|
|
|
|
|
6）Wu X, Robotham JM, Lee E, et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 2012; 8(4): e1002617
|
|
|
|
|
|
7）Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001; 7: 927-33
|
|
|
|
|
|
8）Dorner M, Horwitz JA, Robbins JB, et al. A genetically humanized mouse model for hepatitis C virus infection. Nature. 2011; 474(7350): 208-11
|
|
|
|
|
|
9）Washburn ML, Bility MT, Zhang L, et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 2011; 140(4): 1334-44
|
|
|
|
|
|
10）Date T, Kato T, Kato J, et al. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone. J Virol. 2012 Jul 11. [Epub ahead of print]
|
|
|
|
|
|
11）Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009; 41(10): 1105-9
|
|
|
|
|
|
12）Thomas E, Gonzalez VD, Li Q, et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastro-enterology. 2012; 142(4): 978-88
|
|
|
|
|